Articles & Press Releases
Recent Articles
Overseeing governance and expanding SVS footprint
The Policy and Advocacy Council is composed of the leaders of the Coding and Reimbursement, Government Relations, PAC, Quality and Performance Measures, and VA Vascular Surgeons committees.
Gaining stronger representation for community practice surgeons
Since its inception, the Community Practice Committee has been a valuable resource for surgeons working in settings that serve local communities.
Forging ahead with a new identity and planning for VRIC 2021
The Basic and Translational Research Committee (BTRC) is the new name of the former Research and Education Committee.
Deadlines near for Society, Foundation awards
Applications are due early in 2021 for a number of Society for Vascular Surgery (SVS) and SVS Foundation awards, honors and grants.
Missing your journals? Be sure your dues are paid
Have you paid your 2021 Society for Vascular Surgery dues? If you haven’t, you’re missing access to all of the latest research in the Journal of Vascular Surgery publications.
Cover Story: Ronald L. Dalman, MD, SVS President
While there is little doubt the pandemic has impacted each vascular surgeon and the SVS as a Society in numerous ways, the commitment and dedication of SVS committee, council and task force members to deliver on the mission has remained undaunted.
New link-up for the Document Oversight Committee
The SVS Document Oversight Committee—or the DOC—will be aligning with the SVS Quality Council in order to further its crucial work during the course of 2021.
Preparing for VAM—with alternative options on deck
The Postgraduate Education Committee is hard at work to try to provide the most compelling, timely educational material for SVS members this year, chair Vikram Kashyap, MD, tells Vascular Specialist.
Going global: Society gets new International Mentorship Program
The International Relations Committee has launched a new International Mentorship Program to provide experienced SVS academic mentors for members outside the United States who do not have access to individuals who can assist them in professional growth.
Partnering with SVS PAC in fight over payment cuts
As 2020 brought both the prospect of significant reimbursement challenges for surgical services as well as the tremendous clinical and financial challenges of the pandemic, the SVS Government Relations Committee focused intensely on efforts to head off implementation of steep cuts to 2021 Medicare reimbursements.
Council moves SVS into vascular population health vacuum
The Clinical Practice Council, chaired by William Shutze, MD, has numerous ongoing and new projects and initiatives, including the new SVS Population Health Initiative.
Foundation looks to up contribution levels in 2021
Led by chair Peter Nelson, MD, the SVS Foundation Development Committee works with Foundation chair Peter Lawrence, MD, and the SVS Foundation Board to develop strategies to promote SVS member donations.
Publications Committee braced for major change in year ahead
The Publications Committee is responsible for overseeing, among others, the Journal of Vascular Surgery (JVS) family, the Rutherford textbook and Seminars in Vascular Surgery. After conducting reviews and interviews, committee members as a group put forth candidates for the editorship of JVS and Rutherford to the SVS Executive Committee for its final decisions, according to committee chair Peter Henke, MD.
Grant Helps Amputees Get Up and Walk More Quickly
A grant from the SVS Foundation has helped amputees in the Fresno, Calif. area get up and walking more quickly than is typical.
References for December VA article
The below are the references for the article about research opportunities within the Department of Veterans Affairs, which ran in the December 2020 Specialist.
Audible Bleeding now flows through SVS
The Society for Vascular Surgery would like to welcome the popular Audible Bleeding podcast into its communications family.
NESVS outgoing president makes diversity pitch
During the virtual annual meeting of the New England Society for Vascular Surgery (NESVS), outgoing president Marc L. Schermerhorn, MD, called for the NESVS to follow the lead of the Society for Vascular Surgery (SVS) by creating a diversity task force.
President Dalman reflects on year of adversity—and positive change
The last nine months took away much. The Vascular Annual Meeting (VAM) was canceled. The Vascular Research Initiatives Conference (VRIC) suffered a similar fate—its content latterly resuscitated in virtual form last month. The traditional Society for Vascular Surgery (SVS) presidential handover, too, followed an unorthodox route.
The power of groups: Invest in the SVS PAC
Humans are social animals, and, over time, they have found that their best times are spent in groups. We have just celebrated Thanksgiving, spending time with our most important group, our family, reflecting on our present life situation and giving thanks. And more holidays are to come.
Present Imperfect
Psychologists place great emphasis on the object permanence milestone, but object impermanence is the more brutal lesson. My experience is now familiar and commonplace. Hundreds of thousands of Americans have lost a parent during the pandemic. Our usual methods of closure have been stripped from us. People are dying in isolation, and the ones they leave behind must often grieve alone. Our failure to control the pandemic has had profound psychological consequences beyond the endless death toll. Our country has risen to similar challenges before, and I believe it will again if we learn from the mistakes we made this year. To accomplish this, we must create a complete account of the costs we have endured.
Apply for research awards
Applications for three Society for Vascular Surgery (SVS) Foundation awards are coming up early in the new year.
Study findings support SVS practice guidelines for surveillance of small AAAs
The low rate of events that occur in small abdominal aortic aneurysms (AAAs) supports the continuance of ultrasound surveillance every three years for those that measure between 3–3.9 cm and every year for those 4–4.9cm, researchers found.
VAM 2021 taking shape, schedule changes to expand programming
Though many individual components will remain the same, the 2021 Vascular Annual Meeting (VAM) will have a different look and feel.
Recent Articles
Does this loofah make me look gay?
I doubt many people remember a specific time they watched C-SPAN, let alone the exact date. But on Dec. 18, 2010, there I was, in my Durham, North Carolina, apartment, watching the U.S. Senate vote on the Don’t Ask, Don’t Tell Repeal Act of 2010. Up until 1993, the military forbade openly gay people from serving, even though it was common knowledge that gay men and women have served this country in every war.
Back in the room: Registration now open for Vascular Annual Meeting
Registration for the live, in-person 2021 Vascular Annual Meeting (VAM) has begun—and organizers promise you won’t want to miss the meeting. VAM will be Aug. 18 to 21 in beautiful San Diego, California. Educational programming will be presented across all four days of the conference. The Exhibit Hall will be open Aug. 19 and 20. The registration and housing kick-off is especially welcome, say Society for Vascular Surgery (SVS) leaders, after the COVID-19 pandemic forced cancellation of VAM 2020 and also prompted SVS to move this year’s VAM from June to the August dates.
New SVS vice president, revised bylaws set to be unveiled at June 16 Annual Business Meeting
Members, be sure to register for the June 16 Virtual Annual Business Meeting, the first of two business meetings for 2021. Registration is required to assure A quorum. Register at vascular.org/ABM1Register. The second meeting will be held Saturday, Aug. 21, during the Vascular Annual Meeting (VAM). The Wednesday, June 16, meeting will be from 6 to 7 p.m. Central Daylight Time. Members will hear reports from President Ronald L. Dalman, MD, Secretary Amy Reed, MD, and Treasurer Keith Calligaro, MD. Nominating Committee Chair R. Clement Darling III, MD, will present his report, announce the results of the election for SVS vice president and on bylaws revisions, and introduce the 2021–22 Officers.
DEI One specialty, many voices, diverse perspectives
Over the course of the last year, the Society for Vascular Surgery (SVS) has been on a journey toward fostering greater diversity, equity and inclusion (DEI). From the nadir of #Medbikini almost a year ago, the SVS Executive Board has since embraced and published a report from the SVS DEI Task Force—now a full-fledged committee—that called for action and change.
Being queer without proximal or distal control
“What do you mean your partner? Does that mean a man?” These were among the questions one of my mentors asked me when we were discussing my list of pros and cons regarding the vascular surgery residency training programs to which I would apply. “Yes, my partner is a man.” The expected “oh…” was a reply I heard going to research meetings and throughout the residency interview trail. Unclear was whether this “oh” was one of disappointment, a nervous response, or concern if I would “fit” in vascular surgery. This “oh” haunts me because, in one short utterance, all of my accomplishments can be easily stripped away.
VRIC comes to VAM
This year, the two major meetings of the Society for Vascular Surgery (SVS) that involve the presentation of scientific research are being housed in one tent. The Vascular Research Initiatives Conference (VRIC), typically held in May and geared to translational research, will be held over two sessions Thursday and Friday at the 2021 Vascular Annual Meeting (VAM). More than 25 abstracts will be presented in four sessions covering arterial remodeling and discovery science for venous disease; vascular regeneration, stem cells and wound healing; atherosclerosis and the role of the immune system; and aortopathies and novel vascular devices.
Progress made during year like no other
While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.
Overcoming prejudice and uniting our diverse but vulnerable specialty
The United States has been living through some charged times recently. Our profession is not immune to these conflagrations. In recent times, minority members of the diverse specialty of vascular surgery have seen people who look like them come under attack. And there are politicians and other actors who make it their mission to try to divide us. Against this backdrop, I will relate a personal journey of confronting discrimination and, ultimately, of hope and acceptance.
Patient: ‘Whole body wellness includes the mind and body’
Kathryn Bowser, MD, a member of the Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee, talks to Justin Michel, 29, who identifies as a non-binary trans masculine person, about the patient experience navigating medical care as an individual of minority sexual identity.
Selected content to be live-streamed at VAM
Organizers stress that the best way to experience the 2021 Vascular Annual Meeting (VAM) is in-person, surrounded by friends and colleagues, participating in small-group sessions and seeing all the devices and information available in the Exhibit Hall. All the abstract-based plenary sessions will be live-streamed, as will four international events, specialty lectures and the two presidential addresses. A total of 15 Continuing Medical Education (CME) credits can be earned from among the streamed sessions.
Why donate to the SVS PAC?
A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.
Propofol Use during Catheter-Directed Interventions for Intermediate-Risk Pulmonary Embolism is Associated with Major Adverse Events
A single-center retrospective study suggests avoiding Propofol or intra-procedural sedation during catheter-directed interventions (CDIs) for intermediate-risk pulmonary embolism (PE) because it can have detrimental effects. Propofol is the most commonly used parenteral anesthetic agent in the United States, extensively used for minor and outpatient surgical procedures because of its rapid onset and reversal of action, and in intensive care units for maintenance of coma.
SVS Member Alert
Medtronic is making updated patient management recommendations related to its voluntary recall of the Valiant Navion™ Thoracic Stent Graft on February 17th, which included the patient recommendation for physicians to follow best clinical practice and make best efforts to evaluate patients with at
In the room: Changes aplenty as VAM returns
The Vascular Annual Meeting (VAM) is more anticipated than ever after the annus horribilis of 2020 and the pared-back, digital VAM alternative that was SVS ONLINE. While organizers have previously relayed the changes made for this year’s meeting, Program Committee co-chair Matthew Eagleton, MD, took the opportunity to once again emphasize the significant changes to its structure for 2021, with educational programming presented across all four days— Wednesday through Saturday.
SVS advocacy efforts help spark landmark change in research effort requirements
The recent decision from the National Heart, Lung, and Blood Institute (NHLBI) to reduce the dedicated research effort from 75 to 50% for K awards is a landmark change and will have a tremendous impact on vascular surgeons.The decision affects the June 2021 submission date and applies to vascular, cardiothoracic and trauma surgeons, as well as interventional.
Recent Articles
Does this loofah make me look gay?
I doubt many people remember a specific time they watched C-SPAN, let alone the exact date. But on Dec. 18, 2010, there I was, in my Durham, North Carolina, apartment, watching the U.S. Senate vote on the Don’t Ask, Don’t Tell Repeal Act of 2010. Up until 1993, the military forbade openly gay people from serving, even though it was common knowledge that gay men and women have served this country in every war.
Back in the room: Registration now open for Vascular Annual Meeting
Registration for the live, in-person 2021 Vascular Annual Meeting (VAM) has begun—and organizers promise you won’t want to miss the meeting. VAM will be Aug. 18 to 21 in beautiful San Diego, California. Educational programming will be presented across all four days of the conference. The Exhibit Hall will be open Aug. 19 and 20. The registration and housing kick-off is especially welcome, say Society for Vascular Surgery (SVS) leaders, after the COVID-19 pandemic forced cancellation of VAM 2020 and also prompted SVS to move this year’s VAM from June to the August dates.
New SVS vice president, revised bylaws set to be unveiled at June 16 Annual Business Meeting
Members, be sure to register for the June 16 Virtual Annual Business Meeting, the first of two business meetings for 2021. Registration is required to assure A quorum. Register at vascular.org/ABM1Register. The second meeting will be held Saturday, Aug. 21, during the Vascular Annual Meeting (VAM). The Wednesday, June 16, meeting will be from 6 to 7 p.m. Central Daylight Time. Members will hear reports from President Ronald L. Dalman, MD, Secretary Amy Reed, MD, and Treasurer Keith Calligaro, MD. Nominating Committee Chair R. Clement Darling III, MD, will present his report, announce the results of the election for SVS vice president and on bylaws revisions, and introduce the 2021–22 Officers.
DEI One specialty, many voices, diverse perspectives
Over the course of the last year, the Society for Vascular Surgery (SVS) has been on a journey toward fostering greater diversity, equity and inclusion (DEI). From the nadir of #Medbikini almost a year ago, the SVS Executive Board has since embraced and published a report from the SVS DEI Task Force—now a full-fledged committee—that called for action and change.
Being queer without proximal or distal control
“What do you mean your partner? Does that mean a man?” These were among the questions one of my mentors asked me when we were discussing my list of pros and cons regarding the vascular surgery residency training programs to which I would apply. “Yes, my partner is a man.” The expected “oh…” was a reply I heard going to research meetings and throughout the residency interview trail. Unclear was whether this “oh” was one of disappointment, a nervous response, or concern if I would “fit” in vascular surgery. This “oh” haunts me because, in one short utterance, all of my accomplishments can be easily stripped away.
VRIC comes to VAM
This year, the two major meetings of the Society for Vascular Surgery (SVS) that involve the presentation of scientific research are being housed in one tent. The Vascular Research Initiatives Conference (VRIC), typically held in May and geared to translational research, will be held over two sessions Thursday and Friday at the 2021 Vascular Annual Meeting (VAM). More than 25 abstracts will be presented in four sessions covering arterial remodeling and discovery science for venous disease; vascular regeneration, stem cells and wound healing; atherosclerosis and the role of the immune system; and aortopathies and novel vascular devices.
Progress made during year like no other
While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.
Overcoming prejudice and uniting our diverse but vulnerable specialty
The United States has been living through some charged times recently. Our profession is not immune to these conflagrations. In recent times, minority members of the diverse specialty of vascular surgery have seen people who look like them come under attack. And there are politicians and other actors who make it their mission to try to divide us. Against this backdrop, I will relate a personal journey of confronting discrimination and, ultimately, of hope and acceptance.
Patient: ‘Whole body wellness includes the mind and body’
Kathryn Bowser, MD, a member of the Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee, talks to Justin Michel, 29, who identifies as a non-binary trans masculine person, about the patient experience navigating medical care as an individual of minority sexual identity.
Selected content to be live-streamed at VAM
Organizers stress that the best way to experience the 2021 Vascular Annual Meeting (VAM) is in-person, surrounded by friends and colleagues, participating in small-group sessions and seeing all the devices and information available in the Exhibit Hall. All the abstract-based plenary sessions will be live-streamed, as will four international events, specialty lectures and the two presidential addresses. A total of 15 Continuing Medical Education (CME) credits can be earned from among the streamed sessions.
Why donate to the SVS PAC?
A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.
Propofol Use during Catheter-Directed Interventions for Intermediate-Risk Pulmonary Embolism is Associated with Major Adverse Events
A single-center retrospective study suggests avoiding Propofol or intra-procedural sedation during catheter-directed interventions (CDIs) for intermediate-risk pulmonary embolism (PE) because it can have detrimental effects. Propofol is the most commonly used parenteral anesthetic agent in the United States, extensively used for minor and outpatient surgical procedures because of its rapid onset and reversal of action, and in intensive care units for maintenance of coma.
SVS Member Alert
Medtronic is making updated patient management recommendations related to its voluntary recall of the Valiant Navion™ Thoracic Stent Graft on February 17th, which included the patient recommendation for physicians to follow best clinical practice and make best efforts to evaluate patients with at
In the room: Changes aplenty as VAM returns
The Vascular Annual Meeting (VAM) is more anticipated than ever after the annus horribilis of 2020 and the pared-back, digital VAM alternative that was SVS ONLINE. While organizers have previously relayed the changes made for this year’s meeting, Program Committee co-chair Matthew Eagleton, MD, took the opportunity to once again emphasize the significant changes to its structure for 2021, with educational programming presented across all four days— Wednesday through Saturday.
SVS advocacy efforts help spark landmark change in research effort requirements
The recent decision from the National Heart, Lung, and Blood Institute (NHLBI) to reduce the dedicated research effort from 75 to 50% for K awards is a landmark change and will have a tremendous impact on vascular surgeons.The decision affects the June 2021 submission date and applies to vascular, cardiothoracic and trauma surgeons, as well as interventional.